MedPath

Marine n-3 Polyunsaturated Fatty Acids in Pre- and Postmenopausal Women

Not Applicable
Completed
Conditions
Postmenopause
Premenopause
Interventions
Dietary Supplement: marine n-3 polyunsaturated fatty acids
Dietary Supplement: Thistle oil
Registration Number
NCT00901589
Lead Sponsor
Aalborg University Hospital
Brief Summary

The study is a randomised placebo controlled double-blinded clinical trial where a group of healthy pre- and postmenopausal women is randomised to the intake of fish oil capsules or placebo oil capsules for 12 weeks. Anthropometric measurements(weight, height,blood pressure) blood samples and adipose tissue biopsies will be taken in order to illustrate the effect of marine n-3 PUFAs (fish oil) on the concentration of circulating female hormones and to investigate what impact menopause might have on the ability to incorporate marine n-3 PUFAs into tissues.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
92
Inclusion Criteria
  • age 18-70 years old
  • healthy or well-treated chronic disease
Exclusion Criteria
  • hormone treatment
  • foreseen compliance problem
  • fish oil consumers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Premenopausal women-fishoilmarine n-3 polyunsaturated fatty acids-
Premenopausal-placeboThistle oil-
Postmenopausal women-fishoilmarine n-3 polyunsaturated fatty acids-
Postmenopausal-placeboThistle oil-
Primary Outcome Measures
NameTimeMethod
Content of marine n-PUFAs as percent of total content of fatty acids in adipose tissue and in platelets before and after intervention
Secondary Outcome Measures
NameTimeMethod
Measurement of oestrogen concentrations in blood before and after intervention

Trial Locations

Locations (1)

Center for cardiovascular research, Aalborg Hospital

🇩🇰

Aalborg, Denmark

© Copyright 2025. All Rights Reserved by MedPath